Risks of Adverse Events in Patients with Atrial Fibrillation and Fatty Liver Disease
Author Information
Author(s): Tommaso Bucci, Katarzyna Nabrdalik, Francesco Baratta, Daniele Pastori, Pasquale Pignatelli, Theresa Hydes, Uazman Alam, Francesco Violi, Gregory Y H Lip
Primary Institution: Liverpool Centre for Cardiovascular Science at University of Liverpool
Hypothesis
What is the 1-year risk of all-cause death, thromboembolic events, and bleeding in patients with atrial fibrillation and nonalcoholic fatty liver disease?
Conclusion
Patients with atrial fibrillation and nonalcoholic fatty liver disease have a higher risk of adverse events over one year, especially if they also have cirrhosis or thrombocytopenia.
Supporting Evidence
- NAFLD was associated with a higher risk of composite cardiovascular and hemorrhagic outcomes.
- Patients with AF-NAFLD showed a higher prevalence of obesity, diabetes, and chronic kidney disease.
- NOACs were associated with a better effectiveness and safety profile compared to warfarin.
Takeaway
People with heart problems and fatty liver disease are more likely to have serious health issues, especially if their liver is really sick.
Methodology
This was a retrospective study using a health research network to analyze patients with atrial fibrillation on anticoagulation, comparing those with and without nonalcoholic fatty liver disease.
Potential Biases
Potential underestimation of risks due to reliance on administrative data and possible selection bias.
Limitations
The study relies on ICD-10-CM codes for diagnosis, which may not capture all cases accurately, and it cannot assess liver fibrosis severity.
Participant Demographics
The study included 22,636 patients with AF-NAFLD (mean age 69 years, 46.7% females) and 391,014 patients with AF without liver disease (mean age 72 years, 42.7% females).
Statistical Information
P-Value
HR, 1.54; 95% CI, 1.47-1.61
Confidence Interval
95% CI, 1.47-1.61
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website